Whitebox Advisors LLC Grifols Sa Transaction History

Whitebox Advisors LLC

$2 Billion
Q3 2025

A detailed history of Whitebox Advisors LLC transactions in Grifols Sa stock. As of the latest transaction made, Whitebox Advisors LLC holds 2,621,468 shares of GRFS stock, worth $22.8 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares

2,621,468

Previous 2,621,468 -0.0%

Holding current value

$22.8 Million

Previous $23.7 Million 10.17%

% of portfolio

1.3%

Previous 1.19%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.49 - $9.09 $366,873 - $513,848	-56,529 Reduced 2.11%	2,621,468 $23.7 Million
Q1 2025 May 15, 2025	SELL	$6.62 - $8.71 $8.4 Million - $11.1 Million	-1,269,634 Reduced 32.16%	2,677,997 $19 Million
Q4 2024 Feb 14, 2025	SELL	$6.99 - $9.55 $1.91 Million - $2.62 Million	-273,852 Reduced 6.49%	3,947,631 $29.4 Million
Q3 2024 Nov 14, 2024	BUY	$6.28 - $9.38 $9.54 Million - $14.2 Million	1,519,093 Added 56.21%	4,221,483 $37.5 Million
Q2 2024 Aug 14, 2024	BUY	$6.27 - $7.7 $5.31 Million - $6.52 Million	846,940 Added 45.65%	2,702,390 $17 Million

Q1 2024 May 15, 2024	SELL	$5.47 - $11.38 $9.97 Million - $20.7 Million	-1,822,812 Reduced 49.56%	1,855,450 $12.4 Million
Q4 2023 Feb 14, 2024	BUY	$7.71 - $11.56 $13.2 Million - $19.8 Million	1,712,156 Added 87.08%	3,678,262 $42.5 Million
Q3 2023 Nov 14, 2023	BUY	$8.91 - $10.91 $17.5 Million - $21.5 Million	1,966,106 New	1,966,106 $18 Million
Q4 2022 Feb 14, 2023	SELL	$5.96 - $8.53 $7.14 Million - $10.2 Million	-1,197,665 Reduced 86.82%	181,871 $1.55 Million
Q3 2022 Nov 14, 2022	SELL	$5.95 - $14.3 $2.48 Million - $5.96 Million	-417,069 Reduced 23.21%	1,379,536 $8.5 Million
Q2 2022 Aug 15, 2022	BUY	$10.6 - $13.28 $115,540 - $144,752	10,900 Added 0.61%	1,796,605 $21.3 Million
Q1 2022 May 16, 2022	SELL	$10.37 - $12.73 $12.8 Million - $15.7 Million	-1,236,032 Reduced 40.9%	1,785,705 $20.9 Million
Q4 2021 Feb 14, 2022	SELL	$10.21 - $15.27 $1.29 Million - $1.93 Million	-126,293 Reduced 4.01%	3,021,737 $33.9 Million
Q3 2021 Nov 15, 2021	BUY	$14.07 - $17.3 $2.75 Million - $3.38 Million	195,247 Added 6.61%	3,148,030 $46 Million
Q2 2021 Aug 16, 2021	SELL	$16.62 - $18.94 $864,040 - $984,652	-51,988 Reduced 1.73%	2,952,783 $51.2 Million
Q1 2021 May 14, 2021	SELL	$15.15 - $19.78 $1.84 Million - $2.41 Million	-121,639 Reduced 3.89%	3,004,771 $52 Million
Q3 2020 Nov 13, 2020	BUY	$15.4 - $20.16 $6.93 Million - $9.07 Million	450,132 Added 16.82%	3,126,410 $54.2 Million
Q1 2020 May 15, 2020	BUY	$16.28 - $25.63 $6.21 Million - $9.78 Million	381,486 Added 16.62%	2,676,278 $53.9 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $23.52 $2.09 Million - $2.52 Million	106,965 Added 4.89%	2,294,792 $53.4 Million
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $8.07 Million - $9.25 Million	406,600 Added 22.83%	2,187,827 $43.8 Million
Q1 2019 May 15, 2019	BUY	$18.01 - $20.11 $23 Million - $25.6 Million	1,275,327 Added 252.09%	1,781,227 $35.8 Million
Q4 2018 Feb 14, 2019	SELL	$17.44 - $21.53 $2.79 Million - $3.45 Million	-160,038 Reduced 24.03%	505,900 $9.29 Million
Q3 2018 Nov 14, 2018	BUY	$19.97 - $21.96 $4.87 Million - $5.35 Million	243,737 Added 57.73%	665,938 $14.2 Million
Q2 2018 Aug 14, 2018	BUY	$20.16 - $24.68 $8.51 Million - $10.4 Million	422,201 New	422,201 $9.08 Million
Q1 2018 May 15, 2018	SELL	$20.31 - $24.95 $2.41 Million - $2.96 Million	-118,665 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$20.99 - $23.89 $2.1 Million - $2.39 Million	-100,000 Reduced 45.73%	118,665 $2.72 Million
Q3 2017 Nov 14, 2017	BUY	$20.07 - $21.89 $4.39 Million - $4.79 Million	218,665	218,665 $4.79 Million

Others Institutions Holding GRFS

# of Institutions

200

Shares Held

148M

Call Options Held

76.1K

Put Options Held

58.2K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.91B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whitebox Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whitebox Advisors LLC with notifications on news.

Account

Whitebox Advisors LLC Grifols Sa Transaction History